Market Research Report
Latin America, Middle East & Africa Atherectomy Devices Market (2019-2025)
|Published by||KBV Research||Product code||914132|
|Published||Content info||65 Pages
Delivery time: 1-2 business days
|Latin America, Middle East & Africa Atherectomy Devices Market (2019-2025)|
|Published: September 30, 2019||Content info: 65 Pages||
The LAMEA Atherectomy Devices Market would witness market growth of 7.8% CAGR during the forecast period (2019-2025). The LAMEA Atherectomy Devices market is studied across the Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria and Rest of LAMEA.
The Brazil market dominated the LAMEA Atherectomy Devices Market by Country in 2018, and would continue to be a dominant market till 2025; thereby, achieving a market value of $16 Million by 2025, growing at a CAGR of 7 % during the forecast period. The Argentina market is expected to witness a CAGR of 8.7% during (2019 - 2025). Additionally, The UAE market is expected to witness a CAGR of 7.3% during (2019 - 2025).
The amount of people recovering from atherosclerosis, obesity, and cancer has increased significantly. There has been a continuous increase in the number of individuals receiving angioplasty, interventions, and catheterization to reduce Arterial Plaque (AP). The existence of a large target patient population recovering from Peripheral Artery Diseases (PAD) and hospitals requiring central vascular access in ICUs, outpatients, CathLabs and operation theatres is therefore expected to pose countless growth possibilities for manufacturers in the global atherectomy devices market.
The growing acceptance of minimally invasive processes for atherectomy will increase the demand for atherectomy devices. Such variables fuel the demand for directional atherectomy devices along with the worldwide existence of medical devices across advanced and developing markets.
Based on Type, the market is segmented into Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy and Laser Atherectomy. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
Key market participants present in this market includes Cardiovascular Systems Inc., Avinger Inc., Straub Medical AG, Boston Scientific Corporation, Medtronic PLC (Covidien), Koninklijke Philips N.V., Cardinal Health, Inc. (Cordis), Terumo Corporation (Terumo IS), Abbott Laboratories and B. Braun Melsungen AG.